# KSH01-TCRT Solid Tumors

> **NCT05539833** · EARLY_PHASE1 · RECRUITING · sponsor: **TCRx Therapeutics Co.Ltd** · enrollment: 50 (estimated)

## Conditions studied

- TCR-T Cells
- Refractory Solid Tumors
- Relapsed Solid Tumors

## Interventions

- **DRUG:** KSH01 injection

## Key facts

- **NCT ID:** NCT05539833
- **Lead sponsor:** TCRx Therapeutics Co.Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-19
- **Primary completion:** 2025-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05539833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05539833, "KSH01-TCRT Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05539833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*